Search Results
Jun 03, 2026, 14:25 ET EURÓPSKA KOMISIA SCHVÁLILA LIEK IMDYLLTRA® SPOLOČNOSTI AMGEN NA LIEČBU POKROČILÉHO ŠTÁDIA MALOBUNKOVÉHO KARCINÓMU PĽÚC
(SCLC). J Cancer. 2022;13(9): 2945 – 2953.Sabari JK, Lok BH, Laird JH, et al. Unravelling the biology of SCLC: implications for therapy. Nat Rev Clin Oncol. 2017;14(9): 549 – 561.ClinicalTrials.gov. Záznamy o klinických skúšaniach tarlatamabu. US National Library of Medicine. Cit. apríl
More news about: Amgen
Jun 03, 2026, 13:35 ET EVROPSKÁ KOMISE SCHVÁLILA PŘÍPRAVEK IMDYLLTRA® OD SPOLEČNOSTI AMGEN K LÉČBĚ EXTENZIVNÍHO STADIA MALOBUNĚČNÉHO KARCINOMU PLIC
Cancer. 2022;13(9):2945-2953.Sabari JK, Lok BH, Laird JH, et al. Unravelling the biology of SCLC: implications for therapy. Nat Rev Clin Oncol. 2017;14(9):549-561.ClinicalTrials.gov. Seznam klinických studií s tarlatamabem. Národní knihovna medicíny USA. Navštíveno
More news about: Amgen
Jun 03, 2026, 10:21 ET KOMISJA EUROPEJSA ZATWIERDZA PREPARAT IMDYLLTRA® FIRMY AMGEN DO LECZENIA DROBNOKOMÓRKOWEGO RAKA PŁUCA W POSTACI ROZSIANEJ
JH, et al. Unravelling the biology of SCLC: implications for therapy (Odkrywanie biologii drobnokomórkowego raka płuca: implikacje dla terapii). Nat Rev Clin Oncol. 2017;14(9):549-561.ClinicalTrials.gov. Wpisy dotyczące badań klinicznych tarlatamabu. US National Library
More news about: Amgen
Jun 03, 2026, 09:43 ET ЕВРОПЕЙСКАЯ КОМИССИЯ ОДОБРИЛА ПРЕПАРАТ AMGEN IMDYLLTRA® ДЛЯ ЛЕЧЕНИЯ МЕЛКОКЛЕТОЧНОГО РАКА ЛЕГКОГО НА ЗАПУЩЕННОЙ СТАДИИ
cancer (SCLC). J Cancer. 2022;13(9):2945-2953.Sabari JK, Lok BH, Laird JH, et al. Unravelling the biology of SCLC: implications for therapy. Nat Rev Clin Oncol. 2017;14(9):549-561.ClinicalTrials.gov. Tarlatamab clinical trial listings. US National Library of Medicine. Accessed April 2026.
More news about: Amgen
Jun 03, 2026, 09:27 ET LA CE APRUEBA IMDYLLTRA® DE AMGEN PARA EL CÁNCER DE PULMÓN DE CÉLULAS PEQUEÑAS EN ESTADIO AVANZADO
2022;13(9):2945-2953.Sabari JK, Lok BH, Laird JH, et al. Unravelling the biology of SCLC: implications for therapy. Nat Rev Clin Oncol. 2017;14(9):549-561.ClinicalTrials.gov. Tarlatamab clinical trial listings. US National Library of Medicine. Accessed
More news about: Amgen
Jun 03, 2026, 09:00 ET R1 Capital Launches as Venture Firm Backing Next Generation of Industry Defining Companies
Rev1 Ventures, R1 Capital is a dedicated venture firm operating with its own brand, funds, and investment strategy to support founders from company creation
More news about: R1 Capital
Jun 03, 2026, 09:00 ET AMGEN TO PRESENT NEW DATA ACROSS RARE AUTOIMMUNE AND INFLAMMATORY DISEASES AT EULAR 2026
Med. 2012;366(6):539-551.Perugino CA, Stone JH. IgG4-related disease: an update on pathophysiology and implications for clinical care. Nat Rev Rheumatol. 2020;16(12):702-714.Patel, N, et al. Poster Presentation at European Alliance of Associations for Rheumatology (EULAR) 2026 Congress.
More news about: Amgen
Jun 03, 2026, 00:03 ET Johnson & Johnson presents new data further reinforcing the role of nipocalimab in lowering the autoantibodies driving Sjögren's disease
Sep 1;60(9):4029-4038. doi: 10.1093/rheumatology/keab364. PMID: 338781796 Beydon, M., et al. Epidemiology of Sjögren syndrome. Nat Rev Rheumatol. 2024 Mar;20(3):158-169. doi: 10.1038/s41584-023-01057-6.7 Meudec L, Nocturne G, Mariette X. Update on the Aetiopathogenesis
More news about: Johnson & Johnson
Jun 02, 2026, 10:30 ET Preventing the Spread of Ebola in Displaced Communities Across the Democratic Republic of the Congo
Ebola outbreak in DRC because for the past 20 years the Anglican Church of the Congo has been working to prevent the spread of diseases," said the Most Rev. Georges Titre Ande, Archbishop of Congo and Bishop of Aru. "We have contained Ebola once before and we know that with these rapid community-led campaigns,
More news about: Episcopal Relief & Development
Jun 01, 2026, 21:00 ET Peak Performance: Toyota Introduces the 2026 GRMN Corolla
6-speed intelligent Manual Transmission (iMT) with rev-matchingGear
More news about: Toyota Motor North America
Jun 01, 2026, 16:00 ET EUROPEAN COMMISSION APPROVES AMGEN'S IMDYLLTRA® FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER
cancer (SCLC). J Cancer. 2022;13(9):2945-2953.Sabari JK, Lok BH, Laird JH, et al. Unravelling the biology of SCLC: implications for therapy. Nat Rev Clin Oncol. 2017;14(9):549-561.ClinicalTrials.gov. Tarlatamab clinical trial listings. US National Library of Medicine. Accessed April 2026.
More news about: Amgen
Jun 01, 2026, 11:11 ET UCB Launches Career-Advancing Scholarship Program for Adults Living with Hidradenitis Suppurativa and Immediate Family Members
Cross-Sectional Study. Indian J Dermatol. 2025;70(5):283-286.Sabat R, Jemec GBE, Matusiak L, et al. Hidradenitis suppurativa. Nat Rev Dis Primers. 2020;6(1):18.Jemec GBE. Clinical practice. Hidradenitis suppurativa. N Engl J Med. 2012;366(2):158–64.Date
More news about: UCB
Jun 01, 2026, 04:19 ET Sobi to present new data on pegcetacoplan at ERA 2026
here.References1. Smith RJH, et al. Nat Rev Nephrol. 2019;15(3):129-143. 2. Servais A, et al. Kidney Int. 2012;82(4):454-464.3. Zand L, et al. J Am Soc Nephrol. 2014;25(5):1110-1117.4.
More news about: Swedish Orphan Biotrauma AB
May 28, 2026, 10:22 ET Associated Bank Returns as Title Sponsor of Second Annual Audaxity Bike Ride, Driving Community Impact for Local Cancer Research
varying lengths and difficulty, as well as a flexible virtual participation option to make it accessible for individuals of all abilities and locations. A "Rev Up" event will take place on Friday evening, creating an opportunity for participants and supporters to celebrate the mission and get energized for
More news about: Associated Banc-Corp
May 27, 2026, 09:00 ET Novo Nordisk advances cardiometabolic pipeline with new data featuring CagriSema and zenagamtide at the American Diabetes Association's 2026 Scientific Sessions
JPH; World Obesity Federation. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev. 2017;18(7):715–723.Garvey WT, Mechanick JI, Brett EM, et al. American association of clinical endocrinologists and American College of Endocrinology
More news about: NOVO NORDISK INC.
May 21, 2026, 11:30 ET Business Integra Achieves CMMC Level 2 to Accelerate Secure AI and Legacy Modernization Across the Federal Enterprise
defense, and national security organizations. CMMC Level 2 compliance confirms implementation of all 110 security controls aligned with NIST SP 800-171 Rev. 2.As agencies accelerate adoption of artificial intelligence, automation, and cloud-native platforms, cybersecurity has become central to modernization
More news about: Business Integra Inc
May 20, 2026, 08:38 ET Global Ecumenical Ministry for Inclusion of LGBTQ+ People Relaunches
volunteer Global Coordinator for this ministry, along with the launch of an updated and expanded website. Other Sheep was founded in 1992 by Rev. Dr. Tom Hanks and Mr. John Donor, who were pastors with Metropolitan Community Churches in Argentina and Mexico, respectively. Working in two different
More news about: Other Sheep Global
May 19, 2026, 09:00 ET Domino Unveils New Capabilities to Take AI From Model to Mission-Critical Application
May 19, 2026 /PRNewswire/ -- REV 2026 — At its annual Rev conference today,
More news about: Domino Data Lab
May 18, 2026, 04:47 ET Lundbeck receives orphan drug designation in Japan for asedebart for the treatment of patients with congenital adrenal hyperplasia and Cushing's disease
Metab. 2010;95(11):5110–5121Gadelha M, Vieira Neto L. Clin Endocrinol (Oxf). 2014;80(1):1–12Claahsen-van der Grinten HL, et al. Endocr Rev 2022;43(1):91-159Giuffrida G, et al. J Endocrinol Invest. 2022;45(6):1235–1246Sharma ST, Nieman LK, Feelders RA. Pituitary. 2015;18(2):188–194Lundbeck.
More news about: H. Lundbeck A/S
May 15, 2026, 08:02 ET PainTEQ Launches TRAQ™, A Next-Generation Posterior Approach to SI Joint Fusion
ongoing studies, including TRAQTION, are designed to further characterize the device's real-world performance.© 2026 PainTEQ, LLC • PT-TQ-BRC Rev 000 • painteq.com/patents
More news about: PainTEQ
May 14, 2026, 16:34 ET SkillsUSA's National Leadership & Skills Conference Returns to Atlanta June 1-5 to Showcase America's Future Skilled Workforce
development workshops, two high-energy general sessions and three impactful community service projects benefiting Atlantans.Indy 500 champ to rev up Opening SessionOn Tuesday,
More news about: SkillsUSA
May 13, 2026, 09:00 ET Rev1-Supported Founders Generated $718MM in Economic Impact Amid Challenging Venture Market
Rev1 Ventures.comAbout Rev1 VenturesRev1 Ventures is where founders go to build. As a Midwest venture studio, Rev1 partners with innovators in Saas/AI, deep tech, and life sciences to turn bold ideas into scalable companies. From day one, Rev1 helps startups
More news about: Rev1 Ventures
May 12, 2026, 16:05 ET Velo3D Announces First Quarter 2026 Financial Results
% of Rev
More news about: Velo3D, Inc.
May 11, 2026, 08:00 ET Johnson & Johnson reinforces its leadership in advancing neuropsychiatry with new portfolio and pipeline data at APA and ASCP
doi:10.4088/JCP.20m13699 Sanacora G, Zarate C, Krystal J, et al. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov. 2008;7(5):426-437. doi:10.1038/nrd2462Treatment Advocacy Center. Schizophrenia Fact Sheet. Accessed May 2026.
More news about: Johnson & Johnson
May 07, 2026, 18:19 ET Ferrovial kicks off 2026 with robust operating results
Transactions Rev/Transaction NTE
More news about: Ferrovial